Citizens JMP downgrades Procore stock rating to Market Perform

Citizens JMP downgraded Procore Technologies (PCOR) to Market Perform, despite the construction software firm reporting robust Q2 2025 results that exceeded expectations, including non-GAAP EPS of $0.35 (vs. $0.26 consensus) and revenue of $323.9 million (vs. $312.4 million consensus), alongside accelerating remaining performance obligations. Despite these strong financial beats and positive forward indicators, PCOR's stock declined approximately 2% in after-hours trading, highlighting a market reaction that seemingly prioritizes other concerns, such as recent downward analyst revisions, over the immediate financial performance.

Analysis

Procore Technologies (PCOR) presents a conflicted investment narrative, characterized by strong current performance metrics set against deteriorating analyst sentiment. The company reported a significant second-quarter 2025 earnings beat, with non-GAAP EPS of $0.35 surpassing the $0.26 consensus and revenue of $323.9 million exceeding the $312.4 million expectation. Critically, forward-looking indicators showed strength, with current Remaining Performance Obligations (cRPO) growth accelerating to 21% year-over-year and total RPO growth accelerating to 30% YoY. Despite these robust fundamentals, the market reaction was negative, with the stock falling approximately 2% in after-hours trading. This price action appears driven by a downgrade from Citizens JMP to Market Perform and a broader trend of 17 analysts revising earnings expectations downward. The stock's 4% year-to-date decline, in contrast to the Russell 3000's 7% gain, underscores that investors are currently weighing the analyst cautions more heavily than the firm's demonstrated operational execution and strengthening backlog.

Key Decisions for Investors

• Investors should weigh the company's strong Q2 operational results and accelerating RPO growth against the negative market sentiment signaled by the Citizens JMP downgrade and widespread downward analyst revisions.
• It is critical to monitor whether future revenue growth can re-accelerate in line with the strong RPO figures, as this will be a key determinant in resolving the current conflict between fundamentals and market perception.
• Given the stock's year-to-date underperformance relative to the broader market despite the earnings beat, investors should assess if the current price adequately discounts the risks highlighted by analysts or presents a value opportunity based on strong forward-looking backlog metrics.